Indicators
Indicators
Value
Direction
MACD(12,26,9)
0.347
Buy
RSI(14)
77.288
Buy
STOCH(KDJ)(9,3,3)
82.785
Overbought
ATR(14)
0.974
High Vlolatility
CCI(14)
112.011
Buy
Williams %R
13.817
Overbought
TRIX(12,20)
1.832
Sell
StochRSI(14)
30.390
Sell
Fortrea Holdings Inc
FTRE17.700USD
-0.210-1.17%
Close 12/24, 13:00（ET）Quotes delayed by 15 min
1.63BMarket Cap
LossP/E TTM
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score of Fortrea Holdings Inc
Currency: USD Updated: 2025-12-24Key Insights
Fortrea Holdings Inc's fundamentals are relatively stable, and its growth potential is high.Its valuation is considered fairly valued, ranking 50/404 in the Biotechnology & Medical Research industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Hold, with the highest price target at 11.10.In the medium term, the stock price is expected to trend up.The company has been performing strongly in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Fortrea Holdings Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Analyst Rating
Based on
11
analysts
Hold
Current Rating
11.100
Target Price
-24.90%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Fortrea Holdings Inc Highlights
StrengthsRisks
Fortrea Holdings Inc. is a global contract research organization (CRO), which provides clinical development solutions to the life sciences industry. The Company is engaged in providing biopharmaceutical product and medical device development services to pharmaceutical, biotechnology and medical device customers. The Company offers customers flexible delivery models that include full service, functional service provider, and hybrid service structures. It provides phase I-IV clinical trial management, clinical pharmacology and consulting services. The Company manages its business through a single segment, Clinical Services, that provides services across the clinical pharmacology and clinical development spectrum. The Company has access to all key markets worldwide through a footprint of primary office locations in five countries (the United States, the United Kingdom, China, India and Singapore) with field operations in other jurisdictions worldwide.
Fairly Valued
The company’s latest PE is -1.58, at a medium 3-year percentile range.
Held by CI Select Canadian Equity Fund
Star Investor CI Select Canadian Equity Fund holds 1.82K shares of this stock.
Financial Health
Currency: USD Updated: 2025-12-24The current financial score of Fortrea Holdings Inc is 6.71, ranking 236/404 in the Biotechnology & Medical Research industry. Its financial status is weak, and its operating efficiency is high. Its latest quarterly revenue reached 701.30M, representing a year-over-year increase of 3.91%, while its net profit experienced a year-over-year increase of 43.01%.
Score
Financials
4.68
Key Metrics
Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.
Quality of Earnings
2.64
Operational Efficiency
10.00
Growth Potential
8.81
Shareholder Returns
7.41
Fortrea Holdings Inc's Company Valuation
Currency: USD Updated: 2025-12-24The current valuation score of Fortrea Holdings Inc is 8.81, ranking 16/404 in the Biotechnology & Medical Research industry. Its current P/E ratio is -1.58, which is -3640.22% below the recent high of 55.90 and -8858.62% above the recent low of -141.45.
Score
Valuation Dimensions
P/E
P/B
P/S
P/CF
Industry Ranking 50/404
Relevant data have not been disclosed by the company yet.
Earnings Forecast
Currency: USD Updated: 2025-12-24The current earnings forecast score of Fortrea Holdings Inc is 6.00, ranking 347/404 in the Biotechnology & Medical Research industry. The average price target for Fortrea Holdings Inc is 11.50, with a high of 15.00 and a low of 7.00.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Analyst Rating
Based on
11
analysts
Hold
Current Rating
11.100
Target Price
-24.90%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
534
Total
6
Median
6
Average
Company name
Ratings
Analysts
Fortrea Holdings Inc
FTRE
11
CRISPR Therapeutics AG
CRSP
30
argenx SE
ARGX
25
Intellia Therapeutics Inc
NTLA
25
IQVIA Holdings Inc
IQV
25
Ionis Pharmaceuticals Inc
IONS
24
1
2
3
...
107
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Price Momentum
Currency: USD Updated: 2025-12-24The current price momentum score of Fortrea Holdings Inc is 9.41, ranking 29/404 in the Biotechnology & Medical Research industry. Currently, the stock price is trading between the resistance level at 19.95 and the support level at 13.78, making it suitable for range-bound swing trading.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Indicators
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
Moving Average
Indicators
Value
Direction
MA5
17.530
Buy
MA10
16.716
Buy
MA20
15.266
Buy
MA50
12.481
Buy
MA100
10.797
Buy
MA200
8.354
Buy
Institutional Confidence
Currency: USD Updated: 2025-12-24The current institutional shareholding score of Fortrea Holdings Inc is 10.00, ranking 1/404 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 121.97%, representing a quarter-over-quarter decrease of 1.47%. The largest institutional shareholder is The Vanguard, holding a total of 8.03M shares, representing 8.69% of shares outstanding, with 20.18% decrease in holdings.
Score
Institutional Shareholding
Relevant data have not been disclosed by the company yet.
Shareholder Activity
Name
Shares Held
Chg %
BlackRock Institutional Trust Company, N.A.
Goldman Sachs & Company, Inc.
Corvex Management LP
State Street Investment Management (US)
Sessa Capital
AQR Capital Management, LLC
Fidelity Management & Research Company LLC
Charles Schwab Investment Management, Inc.
DWS Investments UK Limited
1
2
Risk Assessment
Currency: USD Updated: 2025-12-24The current risk assessment score of Fortrea Holdings Inc is 4.06, ranking 119/404 in the Biotechnology & Medical Research industry. The company's beta value is 0.00. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.
Score
Beta vs S&P 500 index
--
VaR
--
240-Day Maximum Drawdown
+78.29%
240-Day Volatility
+103.38%
Return
Best Daily Return
60 days
+23.20%
120 days
+24.46%
5 years
--
Worst Daily Return
60 days
-10.00%
120 days
-14.75%
5 years
--
Sharpe Ratio
60 days
+3.87
120 days
+3.09
5 years
--
Risk Assessment
Maximum Drawdown
240 days
+78.29%
3 years
--
5 years
--
Return-to-Drawdown Ratio
240 days
-0.03
3 years
--
5 years
--
Skewness
240 days
+0.31
3 years
--
5 years
--
Volatility
Realised Volatility
240 days
+103.38%
5 years
--
Standardised True Range
240 days
+4.05%
5 years
--
Downside Risk-Adjusted Return
120 days
+591.15%
240 days
+591.15%
Maximum Daily Upside Volatility
60 days
+83.19%
Maximum Daily Downside Volatility
60 days
+52.65%
Liquidity
Average Turnover Rate
60 days
+2.53%
120 days
+2.92%
5 years
--
Turnover Deviation
20 days
+25.92%
60 days
+39.90%
120 days
+61.18%
Peer Comparison
Biotechnology & Medical Research
Fortrea Holdings Inc
FTRE
7.49 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Amicus Therapeutics Inc
FOLD
8.82 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
IQVIA Holdings Inc
IQV
8.67 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Dynavax Technologies Corp
DVAX
8.56 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
BioCryst Pharmaceuticals Inc
BCRX
8.50 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Krystal Biotech Inc
KRYS
8.46 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
FAQs
How does TradingKey generate the Stock Score of Fortrea Holdings Inc?
The TradingKey Stock Score provides a comprehensive assessment of Fortrea Holdings Inc based on 34 indicators derived from over 100 underlying data points. These indicators are categorised into six key dimensions: financial health, company profile, earnings forecasts, price momentum, institutional confidence, and risk assessment, collectively providing investors with a thorough analysis of Fortrea Holdings Inc’s performance and outlook.
How do we generate the financial health score of Fortrea Holdings Inc?
To generate the financial health score of Fortrea Holdings Inc, we analyse various key financial indicators across several core dimensions, including financial fundamentals, earnings quality, operational efficiency, growth potential, and shareholder returns. By integrating these comprehensive data, the financial health score not only reflects Fortrea Holdings Inc's overall stability, operational efficiency, and growth potential but also captures the investment returns delivered to shareholders. This score aims to support rational decision-making for investors and other stakeholders. A higher score indicates a better financial health of Fortrea Holdings Inc.
How do we generate the company valuation score of Fortrea Holdings Inc?
To generate the company valuation score of Fortrea Holdings Inc, we use several key financial ratios, including P/E, P/B, P/S, and P/CF. These metrics compare Fortrea Holdings Inc’s market value to its earnings, assets, sales, and cash flow, serving as core indicators for assessing company value. By analysing these ratios in an all-round manner, the valuation score reflects not only the market’s current perception of Fortrea Holdings Inc’s value but also its future profitability and growth potential, thereby supporting more informed investment decisions. A higher score indicates a fairer valuation of Fortrea Holdings Inc.
How do we generate the earnings forecast score of Fortrea Holdings Inc?
To calculate the earnings forecast score of Fortrea Holdings Inc, we consider various key indicators such as analyst ratings, financial forecasts, support and resistance levels, and peer comparisons:Current ratings and price targets directly reflect analysts’ expectations, while the upside space indicates their views on the stock’s growth potential.Financial metrics like earnings per share (EPS), revenue, net income, and earnings before interest and taxes (EBIT) are core measures for assessing profitability.By analysing the high, median, and low ranges of the target price, we can identify price trends and determine key support and resistance levels.Comparing these indicators against peers provides context for the stock’s performance and helps
anchor more realistic expectations.These factors together form a comprehensive earnings forecast score that accurately reflects the stock’s expected financial performance and growth potential. A higher score suggests that analysts have a more optimistic outlook on Fortrea Holdings Inc’s future.
How do we generate the price momentum score of Fortrea Holdings Inc?
When generating the price momentum score for Fortrea Holdings Inc, we examine momentum indicators including support and resistance levels as well as volume metrics.Support levels represent price points where buying interest is strong enough to prevent further declines, while resistance levels indicate prices where selling pressure may hinder upward movement. By analysing typical price volume alongside total volume, we assess overall market activity and liquidity. These indicators help identify price trends and potential shifts, enabling more accurate predictions of future earnings.This comprehensive approach can reflect market sentiment and enable rational forecasts of Fortrea Holdings Inc’s prices. A higher score indicates a more stable short-term price trend for Fortrea Holdings Inc.
How do we generate the institutional confidence score of Fortrea Holdings Inc?
To generate the institutional confidence score of Fortrea Holdings Inc, we analyse both the proportion of shares held by institutions and the number of shares they own. A higher institutional ownership percentage indicates strong confidence of professional investors, which is generally a positive signal about Fortrea Holdings Inc’s potential. By examining the number of shares held, we gain deeper insight into institutions’ commitment and attitude toward the stock, as institutional investors typically conduct thorough analysis before making investment decisions. Understanding institutional confidence helps us refine earnings forecasts and provides a more reliable perspective on the company’s future performance and market stability. A higher score indicates greater institutional endorsement of Fortrea Holdings Inc.
How do we generate the risk management score of Fortrea Holdings Inc?
To assess the risk management score of Fortrea Holdings Inc, we examine multiple key indicators related to returns, risk, volatility, and liquidity.The highest and lowest daily returns reflect the potential size of gains and losses, while the Sharpe ratio measures risk-adjusted return performance. On the risk side, we analyse maximum drawdown and the return-to-drawdown ratio to identify extreme loss scenarios. Skewness helps assess the distribution of returns and whether performance may be biased. Volatility indicators—such as realised volatility and standardised true range—reveal price fluctuations. Downside risk-adjusted returns provide insight into potential losses and gains. Lastly, liquidity metrics like average turnover rate and turnover deviation indicate how actively the stock is traded.These indicators together provide a multi-dimensional understanding of Fortrea Holdings Inc’s risk-return profile, serving as core factors of the risk management score. A higher score indicates lower risk on the side of Fortrea Holdings Inc.
